Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientist holds promise for novel oral anti-diabetic drugs

10.06.2009
Promise is held out for the development of novel oral drugs to control blood glucose levels in diabetes patients as the result of research by a Hebrew University of Jerusalem scientist.

For his groundbreaking work, Prof. Shlomo Sasson of the Hebrew University School of Pharmacy has been named one of the winners this year of the Hebrew University’s Kaye Innovation Awards.

Type 2 diabetes is a worldwide epidemic, predicted to affect over 380 million people within the next 20 years. This disease is characterized by high blood glucose levels that lead to severe complications in various organs and tissues. The disease usually results from insufficient secretion and function of the pancreatic hormone insulin that regulates glucose metabolism in peripheral tissues, such as skeletal muscles, fatty tissues and the liver.

Pharmacological anti-diabetic therapy aims at a strict regulation of blood glucose levels to prevent such complications. However, because current oral anti-diabetic drugs often fail, many patients need daily injections of insulin to control their glucose metabolism and reduce blood glucose levels.

The global diabetes therapy market is estimated at around US$26.3 billion in 2009. By 2013 the market is expected to grow to around US$34.5 billion.

Recent work on the molecular mechanisms that regulate glucose transport in skeletal muscles has identified new potential targets for anti-diabetic drugs.

In his research, Sasson, with his colleagues and students, made a unique discovery that high levels of the carbohydrate D-xylose increased the rate of glucose entry into skeletal muscle cells in a non-insulin-dependent manner. They then used it as a prototype molecule for the planning and synthesis of chemical derivatives that may act as potential drugs to lower blood glucose in type 2 diabetic patients.

Some of these derivatives increased significantly the rate of glucose transport in skeletal muscles at very low concentrations. This effect was not achieved by mimicking the classical pathway of insulin action, but by activating the enzyme AMP-activated protein kinase (AMPK). When activated, this enzyme increases the rate of glucose transport in skeletal muscles in the absence of insulin. Therefore, compounds that activate this enzyme can be effective in insulin resistant type 2 diabetic patients or in those that fail to respond to conventional drug therapy. This makes AMPK an extremely attractive target in the development of novel anti-diabetic drugs.

One of the lead compounds developed by Sasson and colleagues effectively reduced blood glucose levels in various animal models of diabetes. This discovery indicates the great potential of these novel derivatives to serve as the basis for development of new drugs to normalize blood glucose levels in diabetic patients.

The Kaye Innovation Awards have been given annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society. This year’s Kaye Awards were presented on June 9 during the Hebrew University Board of Governors meeting in Jerusalem.

For further information:
Jerry Barach, Dept. of Media Relations, the Hebrew University,
Tel: 02-588-2904.
Orit Sulitzeanu, Hebrew University spokesperson, Tel: 054-8820016

Jerry Barach | Hebrew University of Jerusalem
Further information:
http://www.huji.ac.il

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>